
Indapta Therapeutics
Operator of a biotechnology company focused on developing a natural killer cell therapy with potent activity to treat cancer. The company specializes in commercializing a proprietary off-the-shelf, no...
Valuation
$0
Share Price
N/A
Total Raised
$162.3M
Last Round
N/A